Edition:
India

Jubilant Life Sciences Ltd (JULS.BO)

JULS.BO on Bombay Stock Exchange

764.25INR
27 Apr 2017
Change (% chg)

Rs-18.85 (-2.41%)
Prev Close
Rs783.10
Open
Rs772.95
Day's High
Rs778.00
Day's Low
Rs761.00
Volume
134,776
Avg. Vol
131,506
52-wk High
Rs879.10
52-wk Low
Rs294.20

Select another date:

Thu, Apr 27 2017

BRIEF-Jubilant life sciences issuance commercial papers

* Says issuance of commercial papers of INR 750 million Source text for Eikon: Further company coverage:

BRIEF-Jubilant Life Sciences gets ANDA approval for olmesartan medoxomil tablets

* Says Jubilant Life Sciences receives ANDA approval for olmesartan medoxomil tablets

BRIEF-Jubilant Life Sciences issues commercial papers worth 1 bln rupees

* Says issuance of commercial papers of INR 1 billion Source text: http://bit.ly/2nXMIZI Further company coverage:

BRIEF-Jubilant Life Sciences' generic drug gets FDA nod for osteoarthritis, rheumatoid arthritis

* Says Jubilant Life Sciences receives ANDA approval for Celecoxib capsules

BRIEF-Jubilant Life Sciences arm Jubilant Pharma to explore buying specialty pharma business in U.S.

* Board of Jubilant Pharma has approved to negotiate a potential acquisition of a specialty pharma business in U.S. Source text: http://bit.ly/2nMv0o8 Further company coverage:

BRIEF-Jubilant Life Sciences issues commercial papers worth 400 mln rupees

* Says issuance of commercial papers of Rs. 40 crore Source text: http://bit.ly/2ltyCtM Further company coverage:

BRIEF-Jubilant Life Sciences' generic drug for fungal infection gets FDA nod

* Says Jubilant Life Sciences receives ANDA approval for itraconazole capsules

BRIEF-Jubilant Life Sciences approves purchase of 1.87 bln rupees worth preference shares of Jubilant Biosys

* Approved acquisition of optionally convertible redeemable preference shares of Jubilant Biosys aggregating to 1.87 billion rupees Source text: http://bit.ly/2kIuKId Further company coverage:

BRIEF-Jubilant Life Sciences issues NCDs worth 4.95 bln rupees

* Jubilant Life Sciences issues NCDs worth 4.95 billion rupees Source text: (http://bit.ly/2jwwMtL) Further company coverage:

BRIEF-Jubilant Life Sciences seeks members' nod for issue of NCDs worth up to 10 bln rupees

* Seeks members' nod for issue of non-convertible debentures worth up to 10 billion rupees Source text: http://bit.ly/2gmAC4b Further company coverage:

Select another date:

More From Around the Web